{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:32Z","timestamp":1761562052398,"version":"build-2065373602"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.carrev.2016.05.009","type":"journal-article","created":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T15:06:53Z","timestamp":1467040013000},"page":"424-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["When we should say no to TAVR\u2014Defining the line between utility and futility"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0451-9155","authenticated-orcid":false,"given":"Zubair A.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janah","family":"Aji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armaghan","family":"Soomro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeha","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rizwan","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2016.05.009_bb0005","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1016\/j.jacc.2015.10.021","article-title":"Annual outcomes with transcatheter valve therapy: from the STS\/ACC TVT registry","volume":"66","author":"Holmes","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.05.009_bb0010","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2016.05.009_bb0015","series-title":"Clinical practice: insights from the STS\/ACC TVT registry","article-title":"Relationship between procedure volume and outcome for transcatheter aortic valve replacement in U.S","author":"Carroll","year":"2016"},{"key":"10.1016\/j.carrev.2016.05.009_bb0020","first-page":"474","article-title":"Aortic valve replacement for aortic stenosis after previous coronary artery bypass grafting: could early reoperation be prevented?","volume":"15","author":"Verhoye","year":"2006","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.carrev.2016.05.009_bb0025","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jacc.2012.01.001","article-title":"2012 ACCF\/AATS\/SCAI\/STS expert consensus document on transcatheter aortic valve replacement","volume":"59","author":"Holmes","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2016.05.009_bb0030","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.athoracsur.2015.05.010","article-title":"Transapical and transaortic transcatheter aortic valve replacement in the United States","volume":"100","author":"Thourani","year":"2015","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2016.05.009_bb0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.athoracsur.2011.10.056","article-title":"The axillary\/subclavian artery access route for transcatheter aortic valve replacement: a systematic review of the literature","volume":"93","author":"Caceres","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2016.05.009_bb0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.athoracsur.2008.08.017","article-title":"Transapical aortic valve implantation: step by step","volume":"87","author":"Walther","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.carrev.2016.05.009_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jcmg.2013.10.009","article-title":"CT angiography-fluoroscopy fusion imaging for percutaneous transapical access","volume":"7","author":"Kliger","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.carrev.2016.05.009_bb0050","article-title":"Techniques for percutaneous left ventricular apical access what you need to know","volume":"48\u201352","author":"Guerrero","year":"2015","journal-title":"Cardiovasc Intervent Today"},{"key":"10.1016\/j.carrev.2016.05.009_bb0055","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.carrev.2011.10.005","article-title":"Fluoroscopy use and left anterior descending artery angiography to guide transapical access in patients with prior cardiac surgery","volume":"13","author":"Maluenda","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2016.05.009_bb0060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.jcin.2014.01.167","article-title":"Futility, benefit, and transcatheter aortic valve replacement","volume":"7","author":"Lindman","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2016.05.009_bb0065","doi-asserted-by":"crossref","first-page":"949","DOI":"10.7326\/0003-4819-112-12-949","article-title":"Medical futility: its meaning and ethical implications","volume":"112","author":"Schneiderman","year":"1990","journal-title":"Ann Intern Med"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916301531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838916301531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:11:31Z","timestamp":1761559891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838916301531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S1553838916301531"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2016.05.009","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When we should say no to TAVR\u2014Defining the line between utility and futility","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2016.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}